MeSH term
Frequency | Condition_Probility | Humans | 326 | 0.0 |
Prevalence | 2 | 0.0 |
*Adenoviridae | 2 | 6.0 |
Animals | 161 | 0.0 |
Gene Therapy | 4 | 1.0 |
*Gene Transfer Techniques | 2 | 0.0 |
*Genetic Vectors | 6 | 1.0 |
Research Support, Non-U.S. Gov't | 263 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 144 | 0.0 |
Adenovirus E3 Proteins/*genetics | 3 | 75.0 |
Adenoviruses, Human/*genetics | 101 | 63.0 |
Amino Acid Sequence | 96 | 0.0 |
Genome, Viral | 9 | 6.0 |
Molecular Sequence Data | 118 | 0.0 |
Mutation | 34 | 0.0 |
Protein Biosynthesis | 18 | 1.0 |
Rabbits | 8 | 0.0 |
Transcription, Genetic | 39 | 0.0 |
Viral Proteins/*genetics | 15 | 18.0 |
COS Cells | 4 | 0.0 |
Capsid/*genetics | 7 | 35.0 |
*Capsid Proteins | 55 | 45.0 |
Genetic Engineering | 2 | 2.0 |
Mice | 45 | 0.0 |
Mice, Inbred BALB C | 9 | 0.0 |
Recombination, Genetic | 12 | 1.0 |
Adenoviridae/*genetics | 23 | 9.0 |
Antibodies/pharmacology | 2 | 0.0 |
Tumor Cells, Cultured | 25 | 0.0 |
Adenoviruses, Human/genetics/*physiology | 7 | 53.0 |
Capsid/*genetics/metabolism | 2 | 50.0 |
Cell Line, Transformed | 11 | 0.0 |
Hela Cells | 95 | 1.0 |
Receptors, Virus/genetics/*metabolism | 2 | 6.0 |
Recombinant Fusion Proteins/genetics/metabolism | 7 | 0.0 |
Acute Disease | 2 | 0.0 |
Antibodies, Viral/blood | 3 | 2.0 |
Antigens, Viral/*immunology | 6 | 6.0 |
Comparative Study | 43 | 0.0 |
Enzyme-Linked Immunosorbent Assay/*methods | 3 | 2.0 |
Neutralization Tests | 12 | 2.0 |
Cell Line | 113 | 0.0 |
Cercopithecus aethiops | 11 | 0.0 |
English Abstract | 3 | 0.0 |
Virus Replication | 24 | 2.0 |
Conserved Sequence | 10 | 0.0 |
DNA Primers | 3 | 0.0 |
Dimerization | 3 | 0.0 |
Mutagenesis, Site-Directed | 6 | 0.0 |
Protein Structure, Tertiary | 15 | 0.0 |
Recombinant Proteins/chemistry/metabolism | 2 | 0.0 |
Sequence Alignment | 10 | 0.0 |
Sequence Deletion | 5 | 0.0 |
Transcription Factors/chemistry/*metabolism | 3 | 2.0 |
*Transcription, Genetic | 29 | 1.0 |
Transfection | 29 | 0.0 |
Adenovirus E4 Proteins/genetics | 2 | 28.0 |
Cell Nucleus/metabolism | 16 | 0.0 |
DNA-Binding Proteins/*metabolism | 11 | 0.0 |
Hamsters | 32 | 0.0 |
Mesocricetus | 5 | 3.0 |
Microscopy, Confocal | 3 | 0.0 |
*Nuclear Proteins | 2 | 0.0 |
*DNA Replication | 20 | 8.0 |
DNA, Viral/biosynthesis | 7 | 13.0 |
Precipitin Tests | 6 | 0.0 |
*Virus Replication | 20 | 7.0 |
Aged | 11 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
Alzheimer Disease/*metabolism | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 13 | 0.0 |
Female | 26 | 0.0 |
Immunoblotting | 10 | 0.0 |
Immunohistochemistry | 6 | 0.0 |
Male | 22 | 0.0 |
Phosphorylation | 9 | 0.0 |
tau Proteins/*metabolism | 3 | 6.0 |
Binding, Competitive | 6 | 0.0 |
CHO Cells | 5 | 0.0 |
Crystallography, X-Ray | 3 | 0.0 |
Gene Expression | 19 | 0.0 |
Models, Molecular | 10 | 0.0 |
Protein Conformation | 9 | 0.0 |
Protein Structure, Secondary | 5 | 0.0 |
Serotyping | 19 | 9.0 |
Age Factors | 2 | 0.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/metabolism | 2 | 0.0 |
Epitopes/genetics | 5 | 5.0 |
Glycogen Synthase Kinase 3 | 2 | 2.0 |
Glycogen Synthase Kinases | 2 | 3.0 |
DNA Mutational Analysis | 4 | 0.0 |
Point Mutation | 3 | 0.0 |
Polymerase Chain Reaction | 8 | 0.0 |
Base Sequence | 121 | 0.0 |
Binding Sites | 30 | 0.0 |
Green Fluorescent Proteins | 3 | 0.0 |
*Intracellular Signaling Peptides and Proteins | 2 | 0.0 |
Luminescent Proteins/genetics/metabolism | 2 | 1.0 |
Nuclear Proteins/metabolism | 2 | 0.0 |
Protease Inhibitors/pharmacology | 2 | 0.0 |
Trans-Activators/metabolism | 3 | 0.0 |
Transcription Factors/genetics/*metabolism | 2 | 0.0 |
Amino Acid Motifs | 3 | 0.0 |
Cell Compartmentation | 5 | 1.0 |
Estradiol/metabolism | 2 | 2.0 |
Ligands | 2 | 0.0 |
Protein Binding | 16 | 0.0 |
Trans-Activation (Genetics) | 7 | 0.0 |
Transcription Factors/*metabolism | 6 | 0.0 |
Two-Hybrid System Techniques | 4 | 0.0 |
Adenovirus Infections, Human/immunology | 2 | 100.0 |
Adenoviruses, Human/*immunology | 10 | 71.0 |
Antibodies, Viral/immunology | 6 | 7.0 |
Enzyme-Linked Immunosorbent Assay | 4 | 0.0 |
Immune Sera | 3 | 1.0 |
Escherichia coli | 2 | 0.0 |
Plasmids/genetics | 4 | 0.0 |
Receptors, Thyroid Hormone/chemistry/metabolism | 2 | 100.0 |
Recombinant Fusion Proteins | 2 | 0.0 |
Structure-Activity Relationship | 7 | 0.0 |
*Trans-Activation (Genetics) | 5 | 0.0 |
beta-Galactosidase/genetics | 2 | 1.0 |
Genes, Reporter | 7 | 0.0 |
Nuclear Proteins/chemistry/genetics/*metabolism | 2 | 2.0 |
Saccharomyces cerevisiae/genetics | 2 | 0.0 |
Trans-Activators/chemistry/genetics/*metabolism | 3 | 3.0 |
Transcription Factors/chemistry/genetics/*metabolism | 2 | 1.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 30 | 0.0 |
Sequence Homology, Amino Acid | 18 | 0.0 |
Transformation, Genetic | 2 | 1.0 |
Blotting, Western | 8 | 0.0 |
DNA/genetics/metabolism | 3 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 3 | 0.0 |
Models, Genetic | 5 | 0.0 |
Recombinant Fusion Proteins/metabolism | 3 | 0.0 |
Transcription Factor TFIID | 2 | 1.0 |
Transcription Factors, TFII/metabolism | 2 | 5.0 |
Genetic Vectors | 11 | 0.0 |
Protein Structure, Quaternary | 2 | 1.0 |
Adenoviruses, Human/genetics/*metabolism | 6 | 40.0 |
Amino Acid Substitution | 2 | 0.0 |
*Apoptosis | 4 | 0.0 |
Open Reading Frames | 9 | 1.0 |
Adenoviruses, Human/classification/*immunology | 2 | 100.0 |
Antibodies, Monoclonal/immunology | 3 | 0.0 |
Heparin/pharmacology | 3 | 1.0 |
Actins/metabolism | 2 | 0.0 |
Adenoviruses, Human/*physiology | 8 | 50.0 |
Capsid/metabolism | 9 | 69.0 |
*Endocytosis | 4 | 2.0 |
Integrins/metabolism | 3 | 1.0 |
Microscopy, Fluorescence | 4 | 0.0 |
Adenovirus Infections, Human/virology | 2 | 100.0 |
Capsid/genetics | 5 | 20.0 |
DNA, Viral/isolation & purification | 3 | 12.0 |
Polymerase Chain Reaction/*methods | 2 | 0.0 |
*Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Sensitivity and Specificity | 4 | 0.0 |
Sequence Analysis, DNA | 9 | 0.0 |
Sequence Homology, Nucleic Acid | 17 | 0.0 |
DNA/*metabolism | 3 | 0.0 |
*Enhancer Elements (Genetics) | 7 | 2.0 |
Gene Expression Regulation | 12 | 0.0 |
Nuclear Proteins/*metabolism | 4 | 0.0 |
Adenoviruses, Human/genetics/*immunology | 3 | 60.0 |
Cells, Cultured | 29 | 0.0 |
Antibodies, Viral/physiology | 2 | 100.0 |
Solubility | 3 | 0.0 |
Cysteine Endopeptidases/*metabolism | 3 | 1.0 |
Adenoviruses, Human/genetics | 13 | 30.0 |
Bacteriophage lambda/genetics | 4 | 8.0 |
Enhancer Elements (Genetics) | 3 | 0.0 |
Gene Deletion | 4 | 0.0 |
*Nucleic Acid Conformation | 2 | 2.0 |
Flow Cytometry | 5 | 0.0 |
Fluorescent Antibody Technique | 10 | 0.0 |
Jurkat Cells | 3 | 0.0 |
Receptors, Virus/metabolism | 4 | 6.0 |
Cystic Fibrosis Transmembrane Conductance Regulator/genetics | 2 | 3.0 |
Molecular Weight | 37 | 1.0 |
Signal Transduction | 5 | 0.0 |
Adult | 13 | 0.0 |
Child | 5 | 0.0 |
Child, Preschool | 8 | 0.0 |
DNA Restriction Enzymes/metabolism | 5 | 6.0 |
*Genome, Viral | 4 | 5.0 |
Infant | 7 | 0.0 |
Kinetics | 18 | 0.0 |
Virion | 2 | 8.0 |
Genetic Vectors/*immunology | 2 | 50.0 |
Mice, Inbred C57BL | 3 | 0.0 |
Plasmids | 40 | 3.0 |
RNA, Messenger | 4 | 0.0 |
Baculoviridae/genetics | 3 | 1.0 |
Luciferases/metabolism | 2 | 0.0 |
Phenotype | 5 | 0.0 |
Receptors, Virus/*metabolism | 5 | 5.0 |
Recombinant Proteins/metabolism | 4 | 0.0 |
Spodoptera | 3 | 1.0 |
*Gene Expression Regulation, Viral | 8 | 2.0 |
Viral Proteins/genetics/*metabolism | 2 | 3.0 |
Adenovirus E1A Proteins/genetics/*metabolism | 2 | 14.0 |
Nuclear Proteins/genetics/*metabolism | 2 | 0.0 |
Trans-Activators/genetics/*metabolism | 3 | 0.0 |
Cell Nucleus/*metabolism | 3 | 0.0 |
Protein p53/*metabolism | 2 | 0.0 |
Rats | 20 | 0.0 |
Epitope Mapping | 2 | 0.0 |
*Chromosome Fragility | 2 | 1.0 |
Adolescent | 6 | 0.0 |
Adenoviruses, Human/*metabolism | 13 | 52.0 |
Capsid/*metabolism | 3 | 25.0 |
Adenoviruses, Human/classification/*genetics | 3 | 75.0 |
DNA, Viral/genetics | 16 | 10.0 |
Genes, Viral | 28 | 12.0 |
Phylogeny | 3 | 0.0 |
Polymerase Chain Reaction/methods | 3 | 0.0 |
Catalysis | 2 | 0.0 |
Nerve Tissue Proteins/genetics/*metabolism | 2 | 1.0 |
Antibodies, Viral | 4 | 16.0 |
Antigens, Viral/genetics | 3 | 16.0 |
Cross Reactions | 4 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Transduction, Genetic | 2 | 0.0 |
Binding Sites/genetics | 2 | 0.0 |
Chromosome Mapping | 11 | 0.0 |
DNA Primers/genetics | 3 | 0.0 |
DNA-Binding Proteins/*genetics | 4 | 0.0 |
Exons | 2 | 0.0 |
Hybrid Cells | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Trans-Activators/*genetics | 2 | 0.0 |
Cell Survival | 2 | 0.0 |
Mutagenesis | 5 | 0.0 |
Peptides/metabolism | 3 | 1.0 |
Transcription Factors/genetics/metabolism | 2 | 0.0 |
Receptors, Virus/*physiology | 4 | 10.0 |
Adenovirus E3 Proteins/genetics/*immunology | 2 | 100.0 |
Adenoviruses, Human/genetics/immunology/*pathogenicity | 2 | 100.0 |
Cell Membrane/immunology | 2 | 0.0 |
Down-Regulation | 2 | 0.0 |
Immunity, Cellular | 3 | 0.0 |
T-Lymphocytes, Cytotoxic/*immunology | 2 | 0.0 |
Adenoviridae/physiology | 3 | 30.0 |
Biological Transport | 4 | 0.0 |
Cytoplasm/metabolism | 4 | 0.0 |
Models, Biological | 4 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Species Specificity | 17 | 0.0 |
Blotting, Northern | 7 | 0.0 |
Cytomegalovirus/genetics | 2 | 2.0 |
*Promoter Regions (Genetics) | 19 | 0.0 |
RNA, Messenger/genetics | 25 | 0.0 |
Receptors, Virus/physiology | 2 | 8.0 |
Vero Cells | 3 | 1.0 |
Virulence | 3 | 1.0 |
Cell Line, Tumor | 3 | 0.0 |
Protein-Arginine N-Methyltransferase/metabolism | 2 | 40.0 |
Adenoviruses, Human/classification/*physiology | 2 | 100.0 |
Peptide Mapping | 3 | 0.0 |
Saccharomyces cerevisiae/*genetics | 3 | 1.0 |
Temperature | 7 | 0.0 |
Nuclear Proteins/genetics/metabolism | 2 | 1.0 |
*Saccharomyces cerevisiae Proteins | 2 | 0.0 |
*Drosophila Proteins | 2 | 0.0 |
Actins/genetics | 2 | 1.0 |
Adenoviruses, Human/classification/*genetics/metabolism | 2 | 100.0 |
Gene Expression Regulation, Viral | 5 | 1.0 |
Chick Embryo | 3 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
RNA, Messenger/analysis | 3 | 0.0 |
DNA, Viral/analysis/*genetics | 2 | 100.0 |
Pregnancy | 2 | 0.0 |
Macromolecular Substances | 7 | 0.0 |
Trans-Activators/genetics/*physiology | 2 | 2.0 |
Adenoviruses, Human/*chemistry | 3 | 100.0 |
Cell Adhesion | 4 | 0.0 |
Cold | 2 | 1.0 |
Endocytosis | 3 | 0.0 |
Gene Transfer Techniques | 2 | 0.0 |
Microscopy, Electron | 7 | 0.0 |
Recombinant Proteins | 2 | 0.0 |
Biological Markers | 2 | 0.0 |
Middle Aged | 6 | 0.0 |
Lymphocyte Activation | 2 | 0.0 |
Promoter Regions (Genetics) | 12 | 0.0 |
Recombinant Proteins/biosynthesis | 3 | 0.0 |
T-Lymphocytes/immunology/*physiology | 2 | 3.0 |
Epithelial Cells | 2 | 0.0 |
Recombinant Proteins/biosynthesis/genetics | 2 | 2.0 |
Transcription, Genetic/genetics | 2 | 0.0 |
Virus Replication/genetics | 2 | 4.0 |
DNA, Viral | 8 | 5.0 |
Infant, Newborn | 2 | 0.0 |
Adenoviridae/*physiology | 5 | 25.0 |
Adenovirus E1A Proteins/genetics | 2 | 10.0 |
Adenovirus E2 Proteins/genetics | 2 | 25.0 |
3T3 Cells | 3 | 0.0 |
Antibodies, Monoclonal | 8 | 0.0 |
Integrin alphaV | 3 | 11.0 |
Cattle | 5 | 0.0 |
Cloning, Molecular | 32 | 0.0 |
Repetitive Sequences, Nucleic Acid | 6 | 0.0 |
Antigens, Neoplasm/*genetics | 3 | 4.0 |
Genetic Code | 2 | 4.0 |
Adenoviruses, Human/*genetics/physiology | 9 | 75.0 |
DNA Replication | 15 | 3.0 |
*Recombination, Genetic | 4 | 1.0 |
Restriction Mapping | 26 | 1.0 |
Variation (Genetics) | 3 | 0.0 |
Transcription Factors/*genetics/metabolism | 2 | 0.0 |
DNA, Viral/biosynthesis/*metabolism | 3 | 100.0 |
RNA, Viral/metabolism | 6 | 6.0 |
Antigens, CD/*metabolism | 2 | 0.0 |
Integrins/*metabolism | 3 | 2.0 |
DNA/biosynthesis | 2 | 0.0 |
Cytotoxicity, Immunologic | 3 | 0.0 |
Virion/immunology | 2 | 11.0 |
*Protein Biosynthesis | 9 | 1.0 |
Time Factors | 11 | 0.0 |
Poly A/metabolism | 3 | 6.0 |
Transcription Factors/metabolism | 5 | 0.0 |
Viral Proteins/genetics | 7 | 11.0 |
Adenoviridae Infections/*virology | 2 | 100.0 |
*DNA, Viral | 2 | 14.0 |
Disease Models, Animal | 3 | 0.0 |
Trans-Activators/metabolism/*physiology | 2 | 3.0 |
Adenoviruses, Human/*enzymology | 3 | 100.0 |
Escherichia coli/genetics | 5 | 0.0 |
Genetic Complementation Test | 11 | 1.0 |
Hydrogen-Ion Concentration | 6 | 0.0 |
Substrate Specificity | 3 | 0.0 |
*Viral Proteins | 3 | 1.0 |
Epitopes/*immunology | 3 | 1.0 |
Adenoviruses, Human/immunology/*metabolism | 2 | 100.0 |
Capsid/genetics/*metabolism | 2 | 33.0 |
Enzyme Activation | 5 | 0.0 |
Protein Processing, Post-Translational | 4 | 0.0 |
KB Cells | 14 | 16.0 |
Codon | 7 | 1.0 |
T-Lymphocyte Subsets/immunology | 2 | 0.0 |
Methylation | 13 | 2.0 |
Promoter Regions (Genetics)/*genetics | 2 | 0.0 |
Antibody Specificity | 3 | 0.0 |
Adenoviruses, Human/classification/enzymology/*genetics | 2 | 100.0 |
Genes, Viral/*genetics | 7 | 36.0 |
Nucleic Acid Conformation | 12 | 2.0 |
*Phylogeny | 2 | 1.0 |
Cytosol/virology | 3 | 100.0 |
Rats, Wistar | 2 | 0.0 |
Adenoviridae Infections/metabolism | 2 | 50.0 |
Cell Membrane/physiology | 4 | 2.0 |
Clathrin/metabolism | 2 | 4.0 |
Capsid/chemistry/genetics/*metabolism | 2 | 40.0 |
Recombinant Proteins/isolation & purification/metabolism | 2 | 1.0 |
*Cell Transformation, Neoplastic | 8 | 1.0 |
*Genes, Homeobox | 2 | 0.0 |
Transcription Factors/*physiology | 4 | 0.0 |
Receptors, Vitronectin | 2 | 11.0 |
Adenoviruses, Human/*growth & development | 6 | 75.0 |
Immunologic Techniques | 2 | 0.0 |
RNA Polymerase II/*metabolism | 3 | 3.0 |
Spiroplasma/enzymology | 2 | 100.0 |
Haplorhini | 9 | 3.0 |
RNA, Messenger/metabolism | 8 | 0.0 |
RNA, Viral/*metabolism | 4 | 9.0 |
Promoter Regions (Genetics)/genetics | 3 | 0.0 |
Mice, Inbred BALB C/immunology | 2 | 6.0 |
Plaque Assay | 7 | 10.0 |
Capsid/biosynthesis | 2 | 40.0 |
DNA, Viral/*biosynthesis | 5 | 25.0 |
Sulfur Radioisotopes | 3 | 4.0 |
Base Composition | 6 | 2.0 |
Adenoviruses, Human/*genetics/immunology | 3 | 50.0 |
DNA, Viral/*genetics | 29 | 43.0 |
eIF-2 Kinase | 2 | 12.0 |
RNA, Viral/*genetics | 10 | 22.0 |
Virion/*metabolism | 2 | 9.0 |
Radioimmunoassay | 3 | 0.0 |
Adenoviridae/genetics | 2 | 0.0 |
DNA, Viral/metabolism | 7 | 7.0 |
Deoxyribonuclease I | 6 | 4.0 |
Kidney | 8 | 2.0 |
Adenoviruses, Human/*enzymology/genetics | 2 | 66.0 |
DNA-Binding Proteins/genetics/metabolism | 2 | 0.0 |
DNA, Recombinant | 7 | 3.0 |
Adenoviruses, Human/*genetics/growth & development | 3 | 42.0 |
Regulatory Sequences, Nucleic Acid/*genetics | 2 | 2.0 |
Cell Membrane/metabolism | 2 | 0.0 |
In Vitro | 9 | 0.0 |
RNA, Viral/genetics | 15 | 17.0 |
*Cell Transformation, Viral | 20 | 11.0 |
*Gene Expression Regulation | 9 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
DNA-Binding Proteins/isolation & purification/*metabolism | 3 | 4.0 |
Transcription Factors/isolation & purification/*metabolism | 3 | 5.0 |
Dose-Response Relationship, Radiation | 3 | 0.0 |
Ultraviolet Rays | 5 | 0.0 |
Adenoviruses, Human/*genetics/isolation & purification | 3 | 100.0 |
DNA Probes | 2 | 0.0 |
Nucleic Acid Hybridization | 30 | 1.0 |
DNA Restriction Enzymes | 35 | 9.0 |
Exodeoxyribonucleases | 2 | 50.0 |
Gastroenteritis/microbiology | 2 | 28.0 |
Adenovirus Early Proteins | 30 | 44.0 |
Receptor, Epidermal Growth Factor/*metabolism | 2 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 2 | 0.0 |
Cell Division | 2 | 0.0 |
Histocompatibility Antigens Class I/*biosynthesis | 2 | 5.0 |
Adenoviridae/*metabolism | 4 | 40.0 |
*CCAAT-Enhancer-Binding Proteins | 5 | 3.0 |
*Transcription Factors | 7 | 0.0 |
RNA, Messenger/genetics/*metabolism | 2 | 1.0 |
Virus Cultivation | 2 | 4.0 |
RNA, Messenger/*genetics | 10 | 2.0 |
Tetradecanoylphorbol Acetate/pharmacology | 2 | 0.0 |
*Transcription, Genetic/drug effects | 2 | 1.0 |
Lysogeny | 2 | 25.0 |
Oncogene Proteins, Viral/biosynthesis/*genetics | 2 | 28.0 |
DNA, Viral/genetics/*metabolism | 2 | 28.0 |
Hela Cells/metabolism | 16 | 10.0 |
Oligonucleotide Probes | 6 | 0.0 |
Oncogene Proteins, Viral/*genetics | 13 | 22.0 |
RNA, Viral/genetics/isolation & purification | 2 | 10.0 |
Chromosome Deletion | 7 | 1.0 |
*Genes, Viral | 52 | 27.0 |
Viral Proteins/*metabolism | 2 | 3.0 |
Templates, Genetic | 10 | 6.0 |
Adenoviruses, Human/drug effects/*genetics | 2 | 100.0 |
DNA, Viral/*analysis | 9 | 9.0 |
RNA, Messenger/biosynthesis | 5 | 0.0 |
Cell-Free System | 10 | 3.0 |
Cell Membrane Permeability | 2 | 1.0 |
Membrane Proteins/isolation & purification | 2 | 50.0 |
Simian virus 40/*genetics | 4 | 7.0 |
Simplexvirus/*genetics | 3 | 10.0 |
DNA-Binding Proteins/analysis | 2 | 2.0 |
Cell Transformation, Viral | 15 | 5.0 |
Oncogene Proteins, Viral/*physiology | 3 | 8.0 |
Centrifugation, Density Gradient | 2 | 0.0 |
Escherichia coli/*genetics | 4 | 4.0 |
*Mutation | 5 | 0.0 |
Recombinant Proteins/isolation & purification | 2 | 4.0 |
RNA Splicing | 2 | 0.0 |
Cell Differentiation | 2 | 0.0 |
Viral Proteins/biosynthesis | 12 | 37.0 |
DNA/*genetics | 5 | 1.0 |
Oncogene Proteins, Viral/genetics | 2 | 5.0 |
Simian virus 40/genetics | 3 | 2.0 |
DNA-Directed RNA Polymerases/metabolism | 2 | 13.0 |
Electrophoresis | 2 | 0.0 |
*Genes, Regulator | 4 | 3.0 |
*Terminator Regions (Genetics) | 3 | 21.0 |
Adenoviruses, Human/genetics/*growth & development/metabolism | 2 | 100.0 |
Capsid/*biosynthesis/genetics | 4 | 66.0 |
*RNA Splicing | 2 | 0.0 |
RNA, Messenger/*biosynthesis | 2 | 0.0 |
RNA, Viral/biosynthesis | 7 | 14.0 |
Capsid/biosynthesis/*genetics | 2 | 100.0 |
Oncogene Proteins, Viral/biosynthesis/genetics/*physiology | 2 | 40.0 |
DNA/metabolism | 2 | 0.0 |
Aspergillus Nuclease S1 | 3 | 9.0 |
Endonucleases | 2 | 22.0 |
Adenoviridae Infections/*metabolism | 2 | 66.0 |
Autoradiography | 2 | 0.0 |
*Nucleic Acid Hybridization | 3 | 5.0 |
Adenoviruses, Human | 4 | 25.0 |
Genes, Structural | 9 | 1.0 |
Cytopathogenic Effect, Viral | 2 | 1.0 |
*Genes, Structural | 9 | 1.0 |
Doxorubicin/pharmacology | 2 | 0.0 |
Hela Cells/enzymology | 3 | 8.0 |
Computer Graphics | 2 | 3.0 |
DNA, Viral/*metabolism | 4 | 13.0 |
Cell Cycle | 3 | 0.0 |
Lymphocytes/*microbiology | 3 | 30.0 |
Protein Transport | 2 | 0.0 |
*Oncogenes | 3 | 0.0 |
Hela Cells/physiology | 5 | 21.0 |
Immunoassay | 2 | 0.0 |
DNA, Viral/analysis | 7 | 2.0 |
Viral Structural Proteins | 2 | 40.0 |
Chloramphenicol O-Acetyltransferase | 3 | 7.0 |
Poly A/*metabolism | 3 | 14.0 |
*Transfection | 3 | 1.0 |
Adenoviruses, Human/*genetics/metabolism | 4 | 57.0 |
DNA, Recombinant/metabolism | 3 | 15.0 |
Neoplasms, Experimental/*immunology | 3 | 25.0 |
Rats, Inbred Strains | 2 | 0.0 |
Adenoviruses, Human/genetics/*growth & development | 2 | 100.0 |
DNA Replication/*drug effects | 3 | 5.0 |
*DNA Repair | 2 | 0.0 |
Gamma Rays | 2 | 0.0 |
Defective Viruses/genetics | 2 | 13.0 |
Colchicine/pharmacology | 2 | 3.0 |
Carcinoma | 9 | 24.0 |
Mouth Neoplasms | 8 | 44.0 |
Poly A/genetics | 4 | 8.0 |
RNA/genetics | 3 | 2.0 |
Antigens, Viral/*genetics | 2 | 11.0 |
*Deoxyribonucleases, Type II Site-Specific | 2 | 3.0 |
RNA Polymerase II/metabolism | 2 | 1.0 |
Operon | 4 | 15.0 |
RNA/metabolism | 2 | 0.0 |
RNA, Messenger/*metabolism | 3 | 0.0 |
Viral Proteins/*biosynthesis | 5 | 50.0 |
Chickens | 2 | 0.0 |
Oocytes/metabolism | 2 | 1.0 |
*Operon | 2 | 18.0 |
Xenopus | 2 | 0.0 |
*Cloning, Molecular | 3 | 0.0 |
Embryo | 2 | 0.0 |
Adenoviridae/*analysis | 2 | 50.0 |
Chromatography, High Pressure Liquid | 2 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Adenoviruses, Human/metabolism | 2 | 40.0 |
Thymidine Kinase/genetics | 2 | 2.0 |
Peptides/genetics | 2 | 2.0 |
Hybridization, Genetic | 2 | 3.0 |
Antigens, Viral, Tumor | 2 | 33.0 |
Antigens, Neoplasm/*immunology | 2 | 1.0 |
Simian virus 40/*immunology | 2 | 40.0 |
Peptide Biosynthesis | 3 | 6.0 |
RNA, Viral/*biosynthesis | 2 | 9.0 |
Adenoviridae/*growth & development/metabolism | 2 | 100.0 |
*Hybridization, Genetic | 3 | 50.0 |
Trans-Activation (Genetics)/drug effects | 2 | 0.0 |
Calcium-Binding Proteins/metabolism | 2 | 2.0 |
Nocodazole/pharmacology | 2 | 1.0 |
